ebook Munafa Stock Market Course + Intraday & FNO calls  

       

MYGN announcements Myriad Genetics, Inc. announcements and dividends declared USA

Myriad Genetics, Inc. Complete list of announcements declared & dividend announcements by Myriad Genetics, Inc. MYGN

Myriad Genetics, Inc. MYGN listed on USA and deals in Health Care Biotechnology In Vitro In Vivo Diagnostic Substances

Announcements and dividends declared by Myriad Genetics, Inc. MYGN

Wells Fargo Initiates Coverage of Myriad Genetics (MYGN) with Overweight Recommendation
Fintel reports that on August 27, 2024, Wells Fargo initiated coverage of Myriad Genetics (NasdaqGS:MYGN) with a Overweight recommendation.
Announcement as on 29 August 2024

Myriad Genetics (MYGN) Tops Q4 Earnings and Revenue Estimates
Myriad Genetics (MYGN) came out with quarterly earnings of [CO].04 per share, beating the Zacks Consensus Estimate of [CO].02 per share. This compares to loss of [CO].12 per share a year ago. These figures are adjusted for non-recurring
Announcement as on 27 February 2024

Reasons to Hold on to Myriad Genetics (MYGN) Stock for Now
Myriad Genetics, Inc. MYGN has been gaining from robust first-quarter 2022 results. Spectacular improvement in Pharmacogenomics testing revenues, along with growth in tumor profiling and GeneSight test volumes, looks encouraging. However, stiff competition
Announcement as on 26 May 2022

Here's Why You Should Retain Myriad Genetics (MYGN) for Now
Myriad Genetics, Inc. MYGN is well poised for growth in the coming quarters on the ongoing strong recovery in testing volumes. The company’s recent launches of myRisk and RiskScore raise optimism. A strong solvency position is an added advantage. However
Announcement as on 04 October 2021

Here's Why You Should Retain Myriad Genetics (MYGN) for Now
Myriad Genetics, Inc. MYGN is well poised for growth in the coming quarters on the ongoing strong recovery in testing volumes. The company’s recent launches of myRisk and RiskScore raise optimism. A strong solvency position is an added advantage. However
Announcement as on 04 October 2021

Announcements by Myriad Genetics, Inc. first page | Next page |

MYGN Myriad Genetics, Inc. current price & indicator signals

Moving Averages for Myriad Genetics, Inc.

  • 5Day Average: 6.57
  • 12Day Average: 6.4
  • 20Day Average: 6.57
  • 50Day Average: 6.87
  • 100Day Average: 7.11
  • 150Day Average: 6.45
  • 200Day Average: 6.43

MYGN Indicators & signals

Indicator MACD (12,26,9)

6.51, 6.66, -0.19
Indicator MACD is in negative zone

Indicator ADX (14)

26.32, 37.5, 21.88
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 58
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of MYGN Myriad Genetics, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
12 Mon Jan 2026 6.58 6.48 to 7.15 0% 0.87 times
09 Fri Jan 2026 6.58 6.40 to 6.71 0.3% 1.06 times
08 Thu Jan 2026 6.56 6.44 to 6.66 -1.06% 1.04 times
07 Wed Jan 2026 6.63 6.50 to 6.85 1.69% 1.05 times
06 Tue Jan 2026 6.52 6.10 to 6.55 6.19% 1.47 times
05 Mon Jan 2026 6.14 6.09 to 6.23 0% 1.01 times
02 Fri Jan 2026 6.14 6.10 to 6.31 -0.16% 0.88 times
31 Wed Dec 2025 6.15 6.10 to 6.20 -0.32% 0.88 times
30 Tue Dec 2025 6.17 6.15 to 6.30 -2.22% 0.61 times
29 Mon Dec 2025 6.31 6.29 to 6.57 -2.62% 0.83 times
26 Fri Dec 2025 6.48 6.39 to 6.62 -1.07% 1.17 times
24 Wed Dec 2025 6.55 6.38 to 6.56 -0.15% 0.53 times

Videos related to: MYGN announcements Myriad Genetics, Inc. announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

MYGN announcements Myriad Genetics, Inc. announcements and dividends declared USA

 

Back to top